(Q43577897)

24 November 2017

title

Reproducibility of in vivo brain measures of 5-HT2A receptors with PET and. (English)

1 reference

24 November 2017

1 reference

Soares JC

1

1 reference

24 November 2017

van Dyck CH

2

1 reference

24 November 2017

Tan P

3

1 reference

24 November 2017

Zoghbi SS

4

1 reference

24 November 2017

Garg P

5

1 reference

24 November 2017

Soufer R

6

1 reference

24 November 2017

Baldwin RM

7

1 reference

24 November 2017

Fujita M

8

1 reference

24 November 2017

Staley JK

9

1 reference

24 November 2017

Fu X

10

1 reference

24 November 2017

Amici L

11

1 reference

24 November 2017

Seibyl J

12

1 reference

24 November 2017

Innis RB

13

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

24 November 2017

1 reference

24 November 2017

volume

106

1 reference

24 November 2017

issue

2

1 reference

24 November 2017

page(s)

81-93

1 reference

The role of serotonin in the pathophysiology and treatment of schizophrenia

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900071-3

7 January 2021

The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900071-3

7 January 2021

Multicompartmental study of fluorine-18 altanserin binding to brain 5HT2 receptors in humans using positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900071-3

7 January 2021

[18F]setoperone: a new high-affinity ligand for positron emission tomography study of the serotonin-2 receptors in baboon brain in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900071-3

7 January 2021

Loss of brain 5-HT2 receptors in Alzheimer's disease. In vivo assessment with positron emission tomography and [18F]setoperone

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900071-3

7 January 2021

Evaluation of ultrafiltration for the free-fraction determination of single photon emission computed tomography (SPECT) radiotracers: beta-CIT, IBF, and iomazenil

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900071-3

7 January 2021

Time course of 5-HT2A receptor occupancy in the human brain after a single oral dose of the putative antipsychotic drug MDL 100,907 measured by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900071-3

7 January 2021

Parametric imaging of ligand-receptor binding in PET using a simplified reference region model

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900071-3

7 January 2021

Serotonin 5-HT2 receptors in schizophrenia: a PET study using [18F]setoperone in neuroleptic-naive patients and normal subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900071-3

7 January 2021

[11C]MDL 100907, a radioligland for selective imaging of 5-HT(2A) receptors with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900071-3

7 January 2021

PET imaging of cortical S2 serotonin receptors after stroke: lateralized changes and relationship to depression

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900071-3

7 January 2021

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900071-3

7 January 2021

Serotonin 5HT2 receptor imaging in the human brain using positron emission tomography and a new radioligand, [18F]altanserin: results in young normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900071-3

7 January 2021

Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900071-3

7 January 2021

Neurochemical brain imaging investigations of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900071-3

7 January 2021

Imaging of the serotonergic system: interactions of neuroanatomical and functional abnormalities of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900071-3

7 January 2021

A complete remote-control system for reliable preparation of [18F]altanserin.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900071-3

7 January 2021

Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900071-3

7 January 2021

Equilibrium modeling of 5-HT(2A) receptors with [18F]deuteroaltanserin and PET: feasibility of a constant infusion paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900071-3

7 January 2021

MRI-PET registration with automated algorithm

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2801%2900071-3

7 January 2021

10.1016/S0925-4927(01)00071-3

Identifiers

DOI

1 reference

24 November 2017

1 reference